As of 2025-09-15, the Relative Valuation of Cytosorbents Corp (CTSO) is (6.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.94 USD, the upside of Cytosorbents Corp based on Relative Valuation is -745.1%.
The range of the Relative Valuation is (5.79) - (6.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 37.3x - 46.4x | 41.9x |
| Forward P/E multiples | 31.9x - 40.3x | 36.0x |
| Fair Price | (5.79) - (6.26) | (6.05) |
| Upside | -716.7% - -766.7% | -745.1% |
| Date | P/E |
| 2025-09-11 | -6.14 |
| 2025-09-10 | -6.09 |
| 2025-09-09 | -6.42 |
| 2025-09-08 | -6.32 |
| 2025-09-05 | -6.22 |
| 2025-09-04 | -6.28 |
| 2025-09-03 | -6.31 |
| 2025-09-02 | -6.12 |
| 2025-08-29 | -6.07 |
| 2025-08-28 | -6.02 |
| 2025-08-27 | -5.99 |
| 2025-08-26 | -5.99 |
| 2025-08-25 | -5.83 |
| 2025-08-22 | -5.88 |
| 2025-08-21 | -5.43 |
| 2025-08-20 | -5.75 |
| 2025-08-19 | -6.95 |
| 2025-08-18 | -7.08 |
| 2025-08-15 | -7.47 |
| 2025-08-14 | -7.34 |
| 2025-08-13 | -6.95 |
| 2025-08-12 | -6.82 |
| 2025-08-11 | -7.72 |
| 2025-08-08 | -6.44 |
| 2025-08-07 | -5.75 |
| 2025-08-06 | -5.81 |
| 2025-08-05 | -5.89 |
| 2025-08-04 | -5.87 |
| 2025-08-01 | -5.60 |
| 2025-07-31 | -5.47 |
| 2025-07-30 | -5.92 |
| 2025-07-29 | -5.86 |
| 2025-07-28 | -6.06 |
| 2025-07-25 | -6.07 |
| 2025-07-24 | -6.44 |
| 2025-07-23 | -6.57 |
| 2025-07-22 | -6.44 |
| 2025-07-21 | -6.69 |
| 2025-07-18 | -6.63 |
| 2025-07-17 | -6.37 |
| 2025-07-16 | -6.69 |
| 2025-07-15 | -6.63 |
| 2025-07-14 | -6.76 |
| 2025-07-11 | -6.82 |
| 2025-07-10 | -7.34 |
| 2025-07-09 | -7.15 |
| 2025-07-08 | -6.76 |
| 2025-07-07 | -6.63 |
| 2025-07-03 | -7.02 |
| 2025-07-02 | -6.44 |